Trials / Unknown
UnknownNCT04409626
Hyponatraemia and Mortality in Schizophrenic and Bipolar Patients: Protocol for a Bayesian Causal Inference Study
Is Hyponatraemia a Risk Factor for Mortality in Schizophrenic and Bipolar Patients? Protocol for a Bayesian Causal Inference Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 31,740 (estimated)
- Sponsor
- Zealand University Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study seeks to investigate if hyponatraemia be a direct contributor to death in schizophrenic and bipolar patients, and gauge the potential role of somatic comorbidity and psychotropic polypharmacy, with emphasis on antipsychotics and antidepressants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Plasma sodium level (continuous variables) | Observational study, so the exposures of interest (5-year mean and minimum plasma sodium) are not administered to the patients. Ultimately, our interest is in hyponatraemia. |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2020-07-01
- Completion
- 2020-08-01
- First posted
- 2020-06-01
- Last updated
- 2020-06-01
Source: ClinicalTrials.gov record NCT04409626. Inclusion in this directory is not an endorsement.